Efficacy of PD‐1/PD‐L1 inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in China

BACKGROUND: There is only limited knowledge of the treatment responses and clinical outcomes of immune checkpoint inhibitors (ICIs) in driver gene‐negative non‐small cell lung cancer (NSCLC) patients with brain metastases (BM). This study aims to assess the efficacy of immunotherapy in these patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Jiamin, Li, Hui, Yu, Xiaoqing, Yu, Sizhe, Chen, Kaiyan, Pan, Guoqiang, Xie, Mingying, Li, Na, Zhou, Zichao, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590903/
https://www.ncbi.nlm.nih.gov/pubmed/34596346
http://dx.doi.org/10.1111/1759-7714.14171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590903/
https://www.ncbi.nlm.nih.gov/pubmed/34596346
http://dx.doi.org/10.1111/1759-7714.14171

Ejemplares similares